{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:06:24Z","timestamp":1789754784124,"version":"4.0.1"},"reference-count":50,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,12,7]],"date-time":"2009-12-07T00:00:00Z","timestamp":1260144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2010,3]]},"abstract":"<jats:sec>\n                    <jats:label\/>\n                    <jats:p>\n                      <jats:italic>Aliment Pharmacol Ther<\/jats:italic>\n                      \u2002\n                      <jats:bold>31<\/jats:bold>\n                      , 537\u2013547\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>\n                      <jats:bold>Background\u2002<\/jats:bold>\n                      Hepatic encephalopathy, both overt and minimal, forms a continuum of cognitive change in cirrhosis. Strategies to diagnose and treat hepatic encephalopathy have evolved considerably.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Aim<\/jats:bold>\n                      To examine the updated diagnostic and treatment strategies for hepatic encephalopathy.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Methods\u2002<\/jats:bold>\n                      Techniques for the clinical, psychometric and neurophysiological evaluation of hepatic encephalopathy are reviewed. The methods reviewed include pure clinical scales (West\u2010Haven), psychometric tests (PSE\u2010syndrome test), neurophysiological tests (EEG, Critical flicker frequency, CFF) and computerized tests (Inhibitory control test, ICT).\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Results\u2002<\/jats:bold>\n                      Clinical scales are limited, whereas psychometric tests (specifically PSE\u2010syndrome test), CFF and ICT can be used to diagnose minimal hepatic encephalopathy. However, there is no single test that can capture the entire spectrum of cognitive impairment. Treatment options and goals depend on the acuity of hepatic encephalopathy. In\u2010patient management should concentrate on supportive care, precipitating factor reversal and lactulose and\/or rifaximin therapy. Out\u2010patient therapy should aim to prevent recurrences, and both lactulose and rifaximin have evidence to support their use.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>Conclusions\u2002<\/jats:bold>\n                      Diagnostic techniques for hepatic encephalopathy range from simple scales to sophisticated tools. Treatment options depend on the stage of hepatic encephalopathy. The future challenge is to evaluate cognitive function as a continuum with clinically relevant outcomes and to develop well\u2010tolerated and inexpensive treatments for hepatic encephalopathy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1365-2036.2009.04211.x","type":"journal-article","created":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T21:38:25Z","timestamp":1265060305000},"page":"537-547","source":"Crossref","is-referenced-by-count":201,"title":["Review article: the modern management of hepatic encephalopathy"],"prefix":"10.1111","volume":"31","author":[{"given":"J. S.","family":"BAJAJ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,2]]},"reference":[{"key":"e_1_2_9_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.31250"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1746-6342.2006.03215.x"},{"key":"e_1_2_9_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2004.11.028"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.07.021"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1746-6342.2006.03216.x"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(57)90005-3"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)91639-0"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21593"},{"key":"e_1_2_9_10_2","first-page":"1262","article-title":"Neomycin in the treatment of hepatic coma","volume":"273","author":"Dawson AM","year":"1957","journal-title":"Lancet"},{"key":"e_1_2_9_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.160"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.7"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2007.03394.x"},{"key":"e_1_2_9_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-9896-z"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-007-9061-6"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.30957"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2003.50062"},{"key":"e_1_2_9_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23216"},{"key":"e_1_2_9_19_2","volume-title":"Clinical Features of Hepatic Encephalopathy","author":"Weissenborn K","year":"2003"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00026-5"},{"key":"e_1_2_9_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-005-7919-z"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ne.13.030190.000325"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21586"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.04.022"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.09.040"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.10.015"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00129-5"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1023\/B:MEBR.0000043977.11113.2a"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21586"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.06.043"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.14.8301"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2007.01048.x"},{"key":"e_1_2_9_33_2","unstructured":"WechslerD.Wechsler Adult Intelligence Scale\u2010III: Psychological Corp;1999."},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510260606"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/02841850701308378"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21533"},{"key":"e_1_2_9_37_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005556826152"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1746-6342.2006.03218.x"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.09.2968"},{"key":"e_1_2_9_40_2","first-page":"617","article-title":"Current trends in the treatment of hepatic encephalopathy","volume":"5","author":"Al Sibae MR","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20905"},{"key":"e_1_2_9_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003044.pub2"},{"key":"e_1_2_9_43_2","first-page":"1063","article-title":"Lactulose\u2010neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial","volume":"18","author":"Blanc P","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.191"},{"key":"e_1_2_9_45_2","first-page":"11","article-title":"Review: rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy","volume":"149","author":"Alcorn J","year":"2008","journal-title":"ACP J Club"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.28.8.1019"},{"key":"e_1_2_9_47_2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/ACPJC-2004-141-3-059","article-title":"Review: lactulose or lactitol may improve hepatic encephalopathy but may be less effective than antibiotics","volume":"141","author":"Korula J","year":"2004","journal-title":"ACP J Club"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-984576"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.05.056"},{"key":"e_1_2_9_50_2","first-page":"539","article-title":"Rifaximin is Effective in Maintaining Remission in Hepatic Encephalopathy: results of a Large, Randomized, Placebo\u2010Controlled Study","volume":"50","author":"Bass NM","year":"2009","journal-title":"J Hepatol"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21129"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2009.04211.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2009.04211.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T14:46:54Z","timestamp":1698763614000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2009.04211.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["10.1111\/j.1365-2036.2009.04211.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2009.04211.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}